Editorial: the long and winding road to better cancer cell-specific therapies.
Stefan
S
Sleijfer
Erik
E
Wiemer
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016503:Drug Delivery Systems / Q000639:trends*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D006801:Humans; D013584:Sarcoma, Synovial / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism
D000970:Antineoplastic Agents; D066246:ErbB Receptors